Sichuan, China

Ning Jiang

This inventor holds 1 USPTO granted patent. Top assignee: Jumbo Drug Bank Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ning Jiang. Retrieved from https://idiyas.com/inventor/ning-jiang-mq9tnhvj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ning Jiang - Innovator in Pharmaceutical Compounds

Introduction

Ning Jiang is a notable inventor based in Sichuan, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on specific chemical compounds.

Latest Patents

Ning Jiang holds 1 patent for his invention titled "1H-pyrrolo[2,3-c]pyridine compounds and application thereof." This patent encompasses a series of 1H-pyrrolo[2,3-c]pyridine compounds, including those represented by a specific formula and their pharmaceutically acceptable salts. His work in this area showcases the potential applications of these compounds in medicine.

Career Highlights

Ning Jiang is associated with Jumbo Drug Bank Co., Ltd., where he continues to advance his research and development efforts. His expertise in pharmaceutical compounds has positioned him as a valuable asset in the industry.

Collaborations

Ning Jiang has collaborated with notable colleagues, including Chundao Yang and Guanghai Xu. These partnerships have likely contributed to the success of his research and the development of innovative pharmaceutical solutions.

Conclusion

Ning Jiang's contributions to the field of pharmaceuticals through his patented compounds highlight his role as an influential inventor. His work continues to pave the way for advancements in medical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…